Daily Science Podcast
August 3, 2017 - In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target